# SterRx, LLC – FDA Inspection, Jun 28, 2023

Source: https://www.keypedia.com/records/fda_inspections/sterrx-llc/5abddc7d-afba-44e6-8e1f-6fe41c7585b9
Source feed: FDA_Inspections

> FDA inspection 1209342 of SterRx, LLC, June 28, 2023. Classification: Official Action Indicated (OAI). 14 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209342
- Company Name: SterRx, LLC
- Inspection Date: 2023-06-28
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 14

## Related Documents

- [FDA Inspection 1156750 - 2021-11-04](https://www.keypedia.com/records/fda_inspections/sterrx-llc/66ca62f6-c033-45b1-9c2d-7519e21e23fc)
- FDA Inspection 1097893 - 2019-06-07
- [FDA Inspection 1007560 - 2017-03-17](https://www.keypedia.com/records/fda_inspections/sterrx-llc/81ed2d81-bb72-4365-bcc0-842ca18b8695)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/edmund-f-mrak/a43cf86a-c020-4948-bff6-358b2453908a)
- [FDA Associated Person](https://www.keypedia.com/people/pushpa-s-jayasekara/cfd7d22f-b4c2-4002-ae18-b5435815d27d)

Company: https://www.keypedia.com/companies/sterrx-llc/e044d9e8-9ead-4e6d-908e-2741f789519b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
